Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib versus placebo in primary breast cancer
ISRCTN48254013Phase 3Completed
- Sponsor
- Imperial College London
- Start
- Mar 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in breast cancer comparing Placebo with Celecoxib (2 arms). Primary endpoint: Disease-free survival. Started Mar 2006; status: completed.
02
Drugs
celecoxib
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN48254013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN48254013.